CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2011
Cash Flows From Operating Activities:
Net earnings	$ 34,830	$ 23,367	$ 23,727
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Depreciation and amortization	12,168	9,365	9,972
Reserves for credit losses, inventory obsolescence and sales returns	(192)	3,244	303
Share-based compensation expense	3,283	2,392	1,258
Excess tax benefit from exercise of stock options	(1,648)	(740)	(601)
Tax benefit of stock options exercised	0	0	761
Deferred taxes	(991)	1,413	2,424
Payments from lessees directly to lenders-operating leases	(5,567)	(4,371)	(5,184)
Gain on disposal of property, equipment and operating lease equipment	(946)	(1,303)	(1,038)
Gain on sale of notes receivable	(2,997)	(2,915)	0
Excess increase in cash value of life insurance	(107)	(160)	(69)
Other	15	(208)	0
Changes in:
Accounts receivable - net	(17,840)	(50,430)	(11,330)
Notes receivable	550	(4,969)	(3,871)
Inventories-net	8,764	(13,775)	118
Investment in direct financing and sale-type leases-net	18,213	(12,117)	13,544
Deferred costs, other intangible assets, and other assets	(479)	20,126	(10,951)
Accounts payable-equipment	(11,708)	9,735	(33,644)
Accounts payable-trade	4,568	10,218	(3,490)
Salaries and commissions payable, deferred revenue and accrued expenses and other liabilities	1,354	(10,468)	8,673
Net cash provided by (used in) operating activities	41,270	(21,596)	(9,398)
Cash Flows From Investing Activities:
Proceeds from sale of property, equipment and operating lease equipment	1,923	2,176	4,208
Purchases of property, equipment and operating lease equipment	(15,584)	(7,655)	(13,401)
Purchases of short-term investments	(1,233)	(7,396)	0
Maturities of short-term investments	7,647	0	0
Issuance of notes receivable	(87,859)	(65,678)	0
Repayments of notes receivable	26,913	16,713	0
Proceeds from sale or transfer of notes receivable	55,663	35,487	0
Premiums paid on life insurance	(128)	(65)	(146)
Cash used in acquisition, net of cash acquired	0	(11,805)	(1,761)
Net cash used in investing activities	(12,658)	(38,223)	(11,100)
Cash Flows From Financing Activities:
Borrowings of non-recourse and recourse notes payable	32,746	14,137	9,192
Repayments of non-recourse and recourse notes payable	(3,105)	(3)	(5,881)
Repurchase of common stock	(1,890)	(19,418)	(2,652)
Dividends paid	(20,100)	0	0
Proceeds from issuance of capital stock through option exercise	1,167	623	3,679
Payments of contingent consideration	(473)	0	0
Excess tax benefit from share based compensation	1,648	740	601
Net (repayment) borrowings on floor plan facility	(19,660)	21,767	6,232
Net cash (used in) provided by financing activities	(9,667)	17,846	11,171
Effect of exchange rate changes on cash	(3)	(5)	6
Net Increase (Decrease) in Cash and Cash Equivalents	18,942	(41,978)	(9,321)
Cash and Cash Equivalents, Beginning of Period	33,778	75,756	85,077
Cash and Cash Equivalents, End of Period	52,720	33,778	75,756
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	26	21	27
Cash paid for income taxes	24,200	7,544	15,220
Schedule of Non-Cash Investing and Financing Activities:
Purchase of property and equipment included in accounts payable	138	95	49
Purchase of operating lease equipment included in accounts payable	175	0	10
Sales of operating lease equipment included in accounts receivable	34	495	0
Principal payments from lessees directly to lenders	15,872	15,671	27,397
Vesting of share-based compensation	4,648	2,216	1,239
Contingent consideration	0	1,500	0
Dividends declared included in accrued expenses and other liabilities	$ 278	$ 0	$ 0